Genetically engineered mouse models (GEMMs) are instrumental for modelling local and systemic features of complex diseases such as cancer. Non-invasive, longitudinal cell detection and monitoring in tumors, metastases and/or the micro-environment is paramount to achieve a better spatiotemporal understanding of cancer progression and to evaluate therapies in preclinical studies. Bioluminescent and fluorescent reporters marking tumor cells or their microenvironment are valuable for non-invasive cell detection and monitoring in vivo. Here we report the generation of a dual reporter allele allowing simultaneous bioluminescent and fluorescent detection of cells that have undergone Cre-mediated recombination in mice. The single copy knock-in allele in the permissive Collagen I locus was evaluated in the context of several cancer GEMMs, where Cre expression was achieved genetically or by ectopic virus-mediated delivery. The new reporter allele was also combined with popular gene-targeted alleles used in bone, prostate, brain and pancreas cancer research, as well as with alleles inserted into the commonly used Rosa26 and Collagen I loci. This allele is therefore a useful addition to the portfolio of reporters to help advance preclinical research.
A new effLuc/Kate dual reporter allele for tumour imaging in mice
Present address: Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt am Main, Germany.
Present address: ICON plc, Portugal.
Present address: Stanford University, Department of Obstetrics and Gynecololgy, Palo Alto CA, USA.
Present address: 1571 Normandy Drive, Miami Beach, FL 33141, USA
Present address: Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, UK.
- Award Group:
- Funder(s): H2020 European Research Council
- Award Id(s): AdG-741888-CSI-Fun
- Funder(s):
- Award Group:
- Funder(s): H2020 Marie Skodowska-Curie Actions
- Award Id(s): ITN-859860-CANCERPREV
- Funder(s):
- Award Group:
- Funder(s): H2020 European Research Council
- Award Id(s): AdG-322491-HALLMARKS-TO-THERAPY
- Funder(s):
- Award Group:
- Funder(s): H2020 European Research Council
- Award Id(s): AdG-834947-CAN-IT-BARRIERS
- Funder(s):
Latifa Bakiri, Mélanie Tichet, Carolina Marques, Martin K. Thomsen, Elizabeth Allen, Stefanie Stolzlechner, Ke Cheng, Kazuhiko Matsuoka, Massimo Squatrito, Douglas Hanahan, Erwin F. Wagner; A new effLuc/Kate dual reporter allele for tumour imaging in mice. Dis Model Mech 2025; dmm.052130. doi: https://doi.org/10.1242/dmm.052130
Download citation file:
Advertisement
Cited by
Call for Papers – Infectious Disease: Evolution, Mechanisms and Global Health
Showcase your latest research on our upcoming Special Issue: Infectious Disease: Evolution, Mechanisms and Global Health. This issue will be coordinated by DMM Editors Sumana Sanyal and David Tobin alongside Guest Editors Judi Allen and Russell Vance. The deadline for submitting articles to this Special Issue has been extended to Monday 24 February 2025.
Biologists @ 100 - join us in Liverpool in March 2025
We are excited to invite you to a unique scientific conference, celebrating the 100-year anniversary of The Company of Biologists, and bringing together our different communities. The conference will incorporate a DMM programme on antimicrobial resistance on 26 March 2025. Find out more and register to join us in March 2025 in Liverpool, UK. The deadline for abstract submission and early-bird registration is 17 January 2025.
It's about time: the heterochronic background for the 2024 Nobel Prize in Physiology or Medicine
In this Editorial, Bruce Wightman writes about the groundwork laid by investigating the timing of developmental events in nematodes which led to the 2024 Nobel Prize in Physiology or Medicine.
Read & Publish Open Access publishing: what authors say
We have had great feedback from authors who have benefitted from our Read & Publish agreement with their institution and have been able to publish Open Access with us without paying an APC. Read what they had to say.
Other journals from
The Company of Biologists